| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/16/2004 | WO2004078922A2 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 09/16/2004 | WO2004078786A1 Compositions and methods for inhibiting inflammation of vessel walls and formation of neointimal hyperplasia |
| 09/16/2004 | WO2004078713A2 Morpholino based activity mapping |
| 09/16/2004 | WO2004078216A2 Use of a tricyclic antidepressant drug for promoting endocytosis |
| 09/16/2004 | WO2004078192A1 Use of tumor endothelial markers 1, 9 and 17 to promote angiogenesis |
| 09/16/2004 | WO2004078140A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 09/16/2004 | WO2004078130A2 Posh interacting proteins and related methods |
| 09/16/2004 | WO2004078123A2 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
| 09/16/2004 | WO2004067753A3 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof. |
| 09/16/2004 | WO2004053120A3 Regulatory elements in the 5' region of the vr1 gene |
| 09/16/2004 | WO2004047762A3 Methods for treating cancer using porimin as a target |
| 09/16/2004 | WO2004038021A8 Gpr54 knock-out mammals and screening methods using them |
| 09/16/2004 | WO2004032973A3 Use of sns insulator of sea urchin for the gene therapy of erythroid cell diseases |
| 09/16/2004 | WO2004030631A3 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 09/16/2004 | WO2004029213A3 Compositions and methods for delivery of short interfering rna and short hairpin rna |
| 09/16/2004 | WO2004025263A3 Protein and peptide expression for passive immunity |
| 09/16/2004 | WO2003083079A3 Bone generation by gene therapy |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003043583A3 Treatment of immunological disorders using anti-cd30 antibodies |
| 09/16/2004 | WO2003040168A3 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype |
| 09/16/2004 | WO2003033668A3 Correlation of gene expression with chromosome abnormalities in ataxia telangiectasia tumorigenesis |
| 09/16/2004 | WO2002099043A8 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 09/16/2004 | US20040181820 Nucleic acids for transforming fish cells and methods for their use |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040180847 Inhibiting synthesis and function; arresting cellular proliferation |
| 09/16/2004 | US20040180846 Connexin enhances chemotherapy-induced apoptiosis in human cancer cells inhibiting tumor cell proliferation |
| 09/16/2004 | US20040180845 Methods and compositions for modulating glycogen synthesis and breakdown |
| 09/16/2004 | US20040180830 Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
| 09/16/2004 | US20040180442 Low pressure gas accelerated gene gun |
| 09/16/2004 | US20040180440 Modified AAV |
| 09/16/2004 | US20040180434 Materials and methods for nerve grafting, selection of nerve grafts, and in vitro nerve tissue culture |
| 09/16/2004 | US20040180432 Propagating human hematopoietic cells in culture via inoculation of bioreactor nutrient broth with transgenic stromal cells expressing growth factor proteins and perfusion of progenitor cells with medium with subsequent recovery of hematopoietic tissue |
| 09/16/2004 | US20040180429 Spliceosome mediated RNA trans-splicing in stem cells |
| 09/16/2004 | US20040180407 Novel G protein coupled receptor protein, DNA and its ligand |
| 09/16/2004 | US20040180402 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 09/16/2004 | US20040180378 Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
| 09/16/2004 | US20040180371 Nucleotide sequences coding novel serine protease for identifying modulator for diagnosis, treatment and prevention of cell proliferative disorders |
| 09/16/2004 | US20040180354 Comprises polypeptides which are displayable on antigen presenting cells of immune system for use in prevention and treatment of infection and vaccine development; immunotherapy |
| 09/16/2004 | US20040180338 Mutated eukariotic transalation initiation factor 2 alpha kinase3, eif2ak3, in patients with neonatal insuluin-dependant diabetes and multiple epiphyseal dyslapsia (wolcott-rallison syndrome) |
| 09/16/2004 | US20040180335 Comprises nucleotide sequences coding transmembrane protein for diagnosis and treatment of epileptic, autoimmune and nervous system disorders |
| 09/16/2004 | US20040177807 Electrospraying apparatus and method for coating particles |
| 09/16/2004 | DE10058847B4 Verfahren zur Identifizierung von Interferon-therapieempfänglichen Patienten mit chronisch myeloischer Leukämie (CML) A method for the identification of interferon therapy susceptible patients with chronic myeloid leukemia (CML) |
| 09/16/2004 | CA2518490A1 Endothelial cell specific antibodies and uses thereof |
| 09/16/2004 | CA2517981A1 Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-trp |
| 09/16/2004 | CA2517974A1 Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1 |
| 09/16/2004 | CA2517601A1 Infectious flavivirus pseudo-particles containing functional prm-e envelope proteins |
| 09/16/2004 | CA2517525A1 Posh interacting proteins and related methods |
| 09/16/2004 | CA2517145A1 Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 09/16/2004 | CA2517101A1 A modified oligonucleotide for inhibition of growth hormone receptor expression |
| 09/15/2004 | EP1457500A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalophathies |
| 09/15/2004 | EP1457483A1 Cationic lipids with serine backbone |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456650A2 Gfats as modifiers of the p53 pathway and methods of use |
| 09/15/2004 | EP1456647A2 Methods for identifying and validating potential drug targets--- |
| 09/15/2004 | EP1456419A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 09/15/2004 | EP1456408A2 Susceptibility locus for schizophrenia |
| 09/15/2004 | EP1456403A2 Methods of using 48149, a human aminopeptidase family member |
| 09/15/2004 | EP1456383A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 09/15/2004 | EP1456382A2 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456377A2 Syn3 compositions and methods |
| 09/15/2004 | EP1456358A2 Cultured stromal cells and uses thereof |
| 09/15/2004 | EP1456357A2 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 09/15/2004 | EP1456345A2 Apparatus and method for electroporation of biological samples |
| 09/15/2004 | EP1456221A2 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 09/15/2004 | EP1455841A2 Osteopontin-related compositions and methods |
| 09/15/2004 | EP1455840A2 Treatment of human cancer with adenoviral vector expressing tnf-alpha |
| 09/15/2004 | EP1455834A2 Post-coated liposome/lipoplex for targeted drug/gene delivery and lipid linked to a delivery, targeting or stabilising moiety |
| 09/15/2004 | EP1455829A1 Treating vascular disease by inhibiting myeloid differentiation factor 88 |
| 09/15/2004 | EP1455775A2 Methods and compositions for modulating the immune system and uses thereof |
| 09/15/2004 | EP1455754A2 Pharmaceutical compositions in particulate form |
| 09/15/2004 | EP1455580A2 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 09/15/2004 | EP1294881B1 Control of metabolism with compositions of the human 2-oxoglutarate carrier |
| 09/15/2004 | EP1123111B1 Modulation of dna methyltransferase expression by combination therapy |
| 09/15/2004 | EP1023319B1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 09/15/2004 | EP0970106B1 uPAR-MIMICKING PEPTIDES |
| 09/15/2004 | EP0877760B1 Mhc complexes and uses thereof |
| 09/15/2004 | EP0707644B1 Use of pharmaceutical compositions for the treatment of neurodegenerative diseases |
| 09/15/2004 | EP0624195B1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 09/15/2004 | CN1529759A Modular transfection system |
| 09/15/2004 | CN1529758A Novel expression vectors and uses thereof |
| 09/15/2004 | CN1529753A Disease-associated protein |
| 09/15/2004 | CN1529713A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 09/15/2004 | CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells |
| 09/15/2004 | CN1529611A Use of IL-18 inhibitors for treatment or prevention of sepsis |
| 09/15/2004 | CN1529607A Treatment of T cell disorders |
| 09/15/2004 | CN1528464A Method for preparing alpha-interferon plasmid DNA-liposome preparation |
| 09/15/2004 | CN1528452A Method for preparing broad spectrum genetically engineered nano vaccine for malignant tumour |
| 09/15/2004 | CN1166773C Differentiation of adipose stromal cells into osteobalsts |
| 09/15/2004 | CN1166410C Nucleic acid transporters and medicinal compositions for gene therapy |
| 09/15/2004 | CN1166409C Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790938 Human autoantibodies and antiidiotypic antibodies against blood platelet membrane proteins |
| 09/14/2004 | US6790936 Carboxyamido-triazole (cai); sh domains; for use in cancer therapy; drug screening |
| 09/14/2004 | US6790831 For use in testing systemic carnitine deficiency |
| 09/14/2004 | US6790827 Bioconjugates and delivery of bioactive agents |
| 09/14/2004 | US6790826 Human haemopoietic maturation factor |
| 09/14/2004 | US6790823 Compositions and methods for the prevention and treatment of cardiovascular diseases |
| 09/14/2004 | US6790656 Galanin receptors (galr2); involved in various neurological and neurodegenerative disorders and treatments |
| 09/14/2004 | US6790649 Phex gene (phosphate regulating gene with homologies to endopeptidases on x chromosome); for treatment of x-linked hypophosphatemia (xlh), a phosphate homeostasis disorder; retardation, bone, renal and metabolism disorders |